SEC Form 4 · accession 0001562180-17-001256
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey B Kindler
Officer — Executive Chairman · Director
Period of report
Mar 10, 2017
Accepted (ET)
Mar 14, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Mar 10, 2017 | A | 35,000 | A | — | Mar 10, 2020 | Class A Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of vTv Therapeutics Inc. Class A common stock.
- F2Grant vests in three equal annual installments beginning on March 10, 2018.